Difficulty: Medium
Average Score: 95%
Practice
FDA-approved in August 2019, istradefylline is used in the treatment of which of these conditions?
Correct answer
A
Rationale
Istradefylline (Choice A), an adenosine A2A receptor antagonist, was approved in 2019 as an adjunct for Parkinson's disease, improving motor symptoms, making it correct. It's not used for Alzheimer's (Choice B), heart failure (Choice C), or ventricular tachycardia (Choice D), which have unrelated treatments, confirming A.